AstraZeneca
AZN
AZN
1,050 hedge funds and large institutions have $35B invested in AstraZeneca in 2023 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 406 increasing their positions, 348 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,050
Holders Change
-7
Holders Change %
-0.66%
% of All Funds
16.81%
Holding in Top 10
13
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-31.58%
% of All Funds
0.21%
New
86
Increased
406
Reduced
348
Closed
69
Calls
$487M
Puts
$466M
Net Calls
+$21.3M
Net Calls Change
+$20.1M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$756M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$302M |
| 3 |
Morgan Stanley
New York
|
+$189M |
| 4 |
Goldman Sachs
New York
|
+$107M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$88.1M |
